Enzymatica AB (publ) (ENZY.ST)

Sweden · Healthcare · SEK

Key financials

ROE: -34.53%; 2025 (actual)
ROA: -30.78%; 2025 (actual)
Gross Margin: 61.45%; 2025 (actual)
Net Margin: -96.27%; 2025 (actual)
Total Assets: SEK 141,978.00K; 2025 (actual)
Net Income: -SEK 51,890.00K; 2025 (actual)
Valuation: SEK 461,196.71K; 2025 (actual)
Stock Price: SEK 1.90; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	-34.53%	-57.11%	-158.41%	258.49%	77.53%	45.92%
ROA	-30.78%	-43.41%	-53.01%	-57.68%	-60.43%	-61.43%
Gross Margin	61.45%	61.45%	61.45%	61.45%	61.45%	61.45%
Sector average	16.85%	17.71%	17.71%	17.71%	17.71%	17.71%
Net Margin	-96.27%	-96.3%	-96.37%	-96.51%	-96.59%

Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for Enzymatica AB (publ)? It covers the balance sheet, income statement and Equlion model projections.

Total Assets	SEK 141,978.00K	SEK 112,161.84K	SEK 117,985.47K	SEK 127,453.60K	SEK 135,606.09K	SEK 140,463.79K
Sector average	SEK 2,857,190.78K	SEK 2,900,240.60K	SEK 3,045,009.79K	SEK 3,280,286.42K	SEK 3,536,407.14K	SEK 3,762,908.71K

Net Income	-SEK 51,890.00K	-SEK 55,159.87K	-SEK 61,004.62K	-SEK 70,786.64K	-SEK 79,480.52K	-SEK 84,791.52K
Sector average	-SEK 2,851.32K	-SEK 22,027.28K	-SEK 904.69K	-SEK 7,253.84K	-SEK 3,858.45K	-SEK 1,547.00K

Valuation	SEK 461,196.71K	SEK 490,259.20K	SEK 542,207.16K	SEK 629,149.46K	SEK 706,420.39K	SEK 753,624.43K
Sector average	SEK 3,960,502.41K	SEK 5,151,301.60K	SEK 5,189,236.02K	SEK 5,317,343.69K	SEK 5,514,329.75K	SEK 5,636,782.17K

Stock Price	SEK 1.90	SEK 2.02	SEK 2.23	SEK 2.59	SEK 2.91	SEK 3.10
Sector average	SEK 57.22	SEK 48.04	SEK 48.69	SEK 50.45	SEK 52.13	SEK 53.41